Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Laymon

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Neurobiology of Aging|October 26, 2018
Comparison of longitudinal Aβ in nondemented elderly and Down syndromeDana L Tudorascu, Stewart J Anderson, Davneet S Minhas, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 29, 2023
Characterizing the emergence of amyloid and tau burden in Down syndromeMatthew D Zammit, Tobey J Betthauser, Andrew K McVea, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 16, 2025
Genome-wide association of tau neuroimaging and plasma biomarkers in adults with Down syndromeKang-Hsien Fan, Ruyu Shi, Asma Naseer Cheema, et al.
Neurobiology of Aging|August 14, 2022
Amyloid- β and tau deposition influences cognitive and functional decline in Down syndromeMonika Grigorova, Elijah Mak, Stephanie S G Brown, et al.
Tomography (Ann Arbor, Mich.)|June 18, 2020
Multisite Technical and Clinical Performance Evaluation of Quantitative Imaging Biomarkers from 3D FDG PET Segmentations of Head and Neck Cancer ImagesBrian J Smith, John M Buatti, Christian Bauer, et al.
Translational Oncology|April 29, 2014
Errors in Quantitative Image Analysis due to Platform-Dependent Image ScalingThomas L Chenevert, Dariya I Malyarenko, David Newitt, et al.
The Lancet. Neurology|June 20, 2025
Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers: a longitudinal cohort studyShorena Janelidze, Lyduine E Collij, Niklas Mattsson-Carlgren, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 16, 2025
Genome-wide association analyses identify candidate loci for amyloid imaging and plasma biomarkers in adults with Down syndromeM Muaaz Aslam, Lam-Ha T Dang, Ruyu Shi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 25, 2025
PET-measured amyloid beta accumulates at an accelerated rate in Down syndrome compared to neurotypical populationsAndrew McVea, Alexandra DiFilippo, Max McLachlan, et al.
Medical Physics|February 17, 2017
Multi-site quality and variability analysis of 3D FDG PET segmentations based on phantom and clinical image dataReinhard R Beichel, Brian J Smith, Christian Bauer, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Neurobiology of Aging|October 26, 2018
Comparison of longitudinal Aβ in nondemented elderly and Down syndromeDana L Tudorascu, Stewart J Anderson, Davneet S Minhas, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 29, 2023
Characterizing the emergence of amyloid and tau burden in Down syndromeMatthew D Zammit, Tobey J Betthauser, Andrew K McVea, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 16, 2025
Genome-wide association of tau neuroimaging and plasma biomarkers in adults with Down syndromeKang-Hsien Fan, Ruyu Shi, Asma Naseer Cheema, et al.
Neurobiology of Aging|August 14, 2022
Amyloid- β and tau deposition influences cognitive and functional decline in Down syndromeMonika Grigorova, Elijah Mak, Stephanie S G Brown, et al.
Tomography (Ann Arbor, Mich.)|June 18, 2020
Multisite Technical and Clinical Performance Evaluation of Quantitative Imaging Biomarkers from 3D FDG PET Segmentations of Head and Neck Cancer ImagesBrian J Smith, John M Buatti, Christian Bauer, et al.
Translational Oncology|April 29, 2014
Errors in Quantitative Image Analysis due to Platform-Dependent Image ScalingThomas L Chenevert, Dariya I Malyarenko, David Newitt, et al.
The Lancet. Neurology|June 20, 2025
Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers: a longitudinal cohort studyShorena Janelidze, Lyduine E Collij, Niklas Mattsson-Carlgren, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 16, 2025
Genome-wide association analyses identify candidate loci for amyloid imaging and plasma biomarkers in adults with Down syndromeM Muaaz Aslam, Lam-Ha T Dang, Ruyu Shi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 25, 2025
PET-measured amyloid beta accumulates at an accelerated rate in Down syndrome compared to neurotypical populationsAndrew McVea, Alexandra DiFilippo, Max McLachlan, et al.
Medical Physics|February 17, 2017
Multi-site quality and variability analysis of 3D FDG PET segmentations based on phantom and clinical image dataReinhard R Beichel, Brian J Smith, Christian Bauer, et al.
Pageof 9